Comparative Effects of Alternative Nostril Breathing Versus Buteyko Breathing on Control Pause, Dyspnea and Pulmonary Function in Patients With Bronchial Asthma
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Alternative Nostril Breathing Technique along with standard pharmacological management, Buteyko breathing along with pharmacological management.
- Who it may be relevant to
- Registry conditions: Asthma (Diagnosis). Basic parameters: 18 years — 45 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Pakistan
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Bronchial asthma is a chronic inflmmatory airway disease characterized by recurrent episodes of dyspnea, wheezing, and airflow limitation. Dysfunctional breathing pattern and chronic hyperventilation
Detailed description
Bronchial asthma is a chronic inflammatory airway disease in which there are recurrent episodes shortness of breath, wheezing,and limitation in airflow.
Chronic hyperventilation and dysfunctional breathing pattern and commonly contribute to symptom severity and poor asthma control.This study aims to compare the effects of Alternate Nostril Breathing and Buteyko Breathing Technique on control pause, dyspnea, pulmonary function, and asthma control in patients with bronchial asthma.This study aims to compare the effects of Alternate Nostril Breathing and Buteyko Breathing Technique on control pause, dyspnea, pulmonary function, and asthma control in patients with bronchial asthma.This study aims to compare the effects of Alternate Nostril Breathing and Buteyko Breathing Technique on control pause, dyspnea, pulmonary function, and asthma control in patients with bronchial asthma.A total of 40 patients with mild to moderate persistent bronchial asthma will be recruited and randomly allocated into two groups. Group A will receive Alternate Nostril Breathing, while Group B will receive the Buteyko Breathing Technique, along with standard pharmacological management.
The intervention will be conducted over a period of four weeks, with two supervised sessions per week and additional home-based sessions.
Interventions
- Other Alternative Nostril Breathing Technique along with standard pharmacological management
Patients in this group will receive alternative nostril breathing technique along with standard pharmacological management. A total 4 weeks protocol will be followed in which 2 seesions per week will be supervised by physiotherapist and 5 days at home. Alternative nostril breathing will be performed in sitting position. The patient will be asked to place their right thumb to gently close their right nostril. Inhale slowly for 4 sec deeply through left nostril and hold breath for 2-3 sec. Rel - Other Buteyko breathing along with pharmacological management
Patient in this group will receive Buteyko breathing along with pharmacological management. A total 4 weeks protocol will be followed in which 2 sessions per week will be supervised by physiotherapist and 5 days will be done by patients at home. The patient will sit comfortably in upright position. The patients will be give following instructions. Breathe normally for 2-3 minutes (nasal inhalation and nasal exhalation). After relax exhale, hold your breath, use index finger and thumb to plug no
Primary outcome measures
- Control Pause [Time frame: 04 weeks]
- Dyspnea [Time frame: 04 weeks]
- Pulmonary Function Test [Time frame: 04 weeks]
- Asthma Control [Time frame: 04 weeks]
Eligibility criteria
Inclusion criteria
- Age between 18-45 years
- Both genders (male and female)
- Grade 1-3 on mMRC scale of dyspnea
- Asthma severity classes- intermediate,mild persistent and moderate persistent asthma (acc. to NAEPP National Asthma Education and Prevention Program guidlines 2020)
Exclusion criteria
- Patients having acute exerbation of COPD/status asthmaticus
- Patients diagnosed with acute infection
- Patients unable to follow command and instructions
- Asthma patients with >40sec control pause duration
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
Pakistan · 1 center
- Foundation University Islamabad — Islamabad
Identifiers
NCT: NCT07529847 · FUCP/CTR/2026/04